Schrodinger stock fell 11.30 percent on October 16, 2026, 33.10 percent below high
Published on 10/17/2026 at 20:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrading range and valuation
- On October 16, 2026, Schrodinger stock stood 33.10 percent below its 52-week high.
- Schrodinger's market capitalization was USD 1.7 billion as of October 16, 2026.
- Schrodinger stock was last at USD 22.60 on October 16, 2026 at 4:00 p.m. ET on Nasdaq, down 11.30 percent versus the prior close.
- The trailing P/E ratio was minus 30.54 on October 16, 2026.
Schrodinger's next quarterly results are scheduled for November 11, 2026, according to Barron's. The last Nasdaq quote was USD 22.60 on October 16, 2026 at 4:00 p.m. ET, down 11.30 percent from the USD 25.48 prior close.
Results date gives the next marker
The November 11 reporting date gives investors the next fixed point for assessing Schrodinger's software and drug-discovery businesses. Barron's also lists third-quarter 2026 earnings estimates, with average earnings per share at minus USD 0.70. That estimate is separate from the company's reported results and sets a measurable earnings hurdle for the next update.
Stock sits below its yearly high
At USD 22.60, Schrodinger was 33.10 percent below its 52-week high of USD 33.78 and 106.85 percent above its 52-week low of USD 10.95 on October 16, 2026. The completed-session decline therefore left the stock closer to the middle of its yearly range than to its upper boundary. Trading volume reached 2,719,069 shares against an average of 1,873,670 shares on the same date.
Valuation remains loss-based
Schrodinger's market capitalization was USD 1.7 billion as of October 16, 2026. Its trailing P/E ratio was minus 30.54, while no dividend yield was reported. The negative ratio keeps earnings performance central to the November reporting date rather than allowing a dividend metric to frame the valuation.
Comparison with peers
Schrodinger (Nasdaq, USD): minus 11.30 percent, P/E minus 30.54, market capitalization USD 1.7 billion.
Recursion Pharmaceuticals (Nasdaq, USD): minus 16.71 percent, P/E minus 3.33, market capitalization USD 1.9 billion.
AbCellera (Nasdaq, USD): minus 6.94 percent, P/E minus 21.85, market capitalization USD 3.8 billion.
Market value for German investors
Schrodinger's market capitalization stood at USD 1.7 billion on October 16, 2026. The next scheduled quarterly report remains November 11, 2026.
Schrodinger market data
- Company: Schrodinger, Inc.
- ISIN: US80810D1037
- Ticker: SDGR
- Primary exchange: Nasdaq
- Market capitalization: USD 1.7 billion (as of October 16, 2026)
- 52-week range: USD 10.95-USD 33.78 (as of October 16, 2026)
- Sector / Industry: Technology / Software - Application
Market context: Market report S&P 500.
